down arrow

Zhejiang Hisun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000013Z2
CNY
10.64
-0.08 (-0.75%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Zhejiang Hisun Pharmaceutical Co., Ltd.
Why is Zhejiang Hisun Pharmaceutical Co., Ltd. ?
1
With ROE of 5.96%, it has a fair valuation with a 1.34 Price to Book Value
  • Over the past year, while the stock has generated a return of 22.86%, its profits have risen by 631.2% ; the PEG ratio of the company is 0
  • At the current price, the company has a high dividend yield of 2.3
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Zhejiang Hisun Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Hisun Pharmaceutical Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Zhejiang Hisun Pharmaceutical Co., Ltd.
24.88%
1.40
29.34%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.90%
EBIT Growth (5y)
20.81%
EBIT to Interest (avg)
2.76
Debt to EBITDA (avg)
3.34
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.75
Tax Ratio
21.59%
Dividend Payout Ratio
40.74%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.18%
ROE (avg)
6.61%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
1.34
EV to EBIT
18.33
EV to EBITDA
7.64
EV to Capital Employed
1.27
EV to Sales
1.40
PEG Ratio
0.04
Dividend Yield
2.27%
ROCE (Latest)
6.91%
ROE (Latest)
5.96%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
NET PROFIT(9M)

At CNY 371.29 MM has Grown at 240.79%

DEBT-EQUITY RATIO (HY)

Lowest at 35.7 %

RAW MATERIAL COST(Y)

Fallen by -32.95% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY 265.37 MM

-5What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 899.36

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.13%

OPERATING PROFIT(Q)

Lowest at CNY 257.67 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.91 %

Here's what is working for Zhejiang Hisun Pharmaceutical Co., Ltd.
Net Profit
At CNY 283.47 MM has Grown at 194.3%
Year on Year (YoY)
MOJO Watch
Net Profit trend is very positive

Net Profit (CNY MM)

Net Profit
Higher at CNY 283.47 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Debt-Equity Ratio
Lowest at 35.7 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit
Highest at CNY 265.37 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Raw Material Cost
Fallen by -32.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Hisun Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Lowest at 899.36
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at CNY 257.67 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 9.91 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio
Lowest at 3.13%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."